Search results for

The review explains what we do, what we achieved and some of the challenges we faced in 2023/24.

All establishments licensed to carry out activities under the Human Tissue (Quality and

The following guidance has been issued to set out the HTA’s expectations regarding the use of alternative reagents and materials during the processing of t...

Issued 17 August 2009

This page contains information about the SoH

The list below provides guidance on which types of tissues and cells are regulated under the Human Tissue (Quality and Safety for Human Application) Regu

RASRM is a ‘one stop shop’ for research and development professionals across academia, industry, and the NHS.

This guide explains the regulatory requirements for establishments in the Human Application sector.

The Designated Individual (DI) at the licensed establishment is responsible for ensuring suitable practices take place under the authority of the Human Tis...

Guidance for establishments on meeting HTA licensing requirements for the procurement of tumour samples to be used as a starting material in the manufactur...

The Human Fertilisation and Embryology Authority (HFEA) and the Human Tissue Authority (HTA) have been working together to reduce the regulatory overlap re...

New EU regulations for medical devices (MDR) and in-vitro medical devices (IVDR) have been introduced.